Peter Soelkner, Managing Director of Vetter Pharma International GmbH, and Frank Mathias, Ph.D., CEO of Rentschler Biopharma SE explain how the two companies' new collaborative partnership provides new synergies to support customer projects throughout the life cycle.
.svg)
